Company / Current Liabilities per Share
Jade Biosciences, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.13
FY2024
5-year range
$0.13 / $7.32
FY2020-FY2024
Trend
-80.0%
vs FY2023
Sector context
#198 of 208
Health Care
What the data says
Among 208 Health Care companies, Jade Biosciences, Inc. is in the top 5% for current liabilities per share. Improved from $0.32 to $0.13 over the past 2 years.
Based on SEC 10-K filings.
0.13 in FY2024 with a 3-year CAGR of -13.6%.
Improved from $0.32 to $0.13 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -13.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 208This company $0.13 Sector average $26.71
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 80.0% year-over-year.
- Ranks #198 out of 208 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.13 | -80.0% |
| FY2023 | $0.67 | +110.6% |
| FY2022 | $0.32 | +53.3% |
| FY2021 | $0.21 | -97.2% |
| FY2020 | $7.32 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026